Kyowa Kirin
POTELIGEO
Manufacturer:
Kyowa Kirin
Name:
POTELIGEO
HCPCS Code Descriptor:
Injection, mogamulizumab-kpkc, 1 mg
Category:
J Code
HCPCS:
J9204
NDC(s):
42747-0761-01
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
POTELIGEO is an Oncology drug manufactured by Kyowa Kirin and administered via the Intravenous route of administration. The J Code: J9204 is aligned to the drug POTELIGEO.
Access Pricing and More By Registering
HCPCS Added Date:
10/1/19
HCPCS Effective Date:
10/1/19
HCPCS Short Description:
Inj mogamulizumab-kpkc, 1 mg
Billing and Coding Guide:
https://www.poteligeohcp.com/assets/files/POTELIGEO-Billing-and-Coding-Guide.pdf
Patient Assistance:
https://www.kyowakirincares.com/poteligeo-patients/
